A Phase 3, Multicenter, Randomized, Double-blind Study of the Efficacy and Safety of Rezafungin for Injection versus Intravenous Caspofungin Followed by Optional Oral Fluconazole Step-down in the Treatment of Subjects with Candidemia and/or Invasive Candidiasis (The ReSTORE Study)

Project: Research

Project Description

NMA HREC Reference Number: HREC/50646/Alfred-2019
NMA SSA Reference Number: SSA/50646/MonH-2019-182751(v1)
Monash Health Ref: RES-19-0000-590X
StatusActive
Effective start/end date22/08/1921/08/24

Keywords

  • clinical trial
  • phase 3 study
  • Candidemia
  • treatment efficacy